176,855 startups read our weekly essays.

nfx-brand-symbols

NFX Bio: Investing in Scientist-Founders from the Very Beginning with Omri Amirav-Drory

Omri Amirav-Drory, Ph.D. · @omri_drory · Apr 2022

We started NFX Bio as a home for Scientist-Founders working at the intersection of tech and bio to solve humanity’s biggest challenges.

You might think a self-driving car or the latest NFT drop is advanced technology. But a humble plant can do things technology can’t. Biology is the most advanced technology on earth. And there is something even more advanced than biology: Entrepreneurship. Founders can imagine the world as it should be. They can rip a hole in this universe and take us to a new one — and then build it.

Today, instead of overloading you with VC advice, here’s a simple 3-part exercise for explaining what you’re working on:

1. Is it big enough?
2. Do you have defensible magic?
3. Are you the right person for this project?

This simple storytelling framework works for a first meeting with investors, for recruiting, for partners and more.


nfx-brand-symbols
Stay up to speed
Weekly resources, news, and stories. Be the first to know and get insider tips.
176,855 startups read our weekly essays.
Profile picture of Omri Amirav-Drory, Ph.D.
Omri Amirav-Drory, Ph.D.
2-time scientist-founder. Founder at Genome Compiler, founding CEO of Tech.bio. Head of NFX Bio.
Tel Aviv/Menlo Park
Author
Connect with
Omri Amirav-Drory, Ph.D.

As Founders ourselves, we respect your time. That’s why we built BriefLink, a new software tool that minimizes the upfront time of getting the VC meeting.

Simply tell us about your company in 9 easy questions, and you’ll hear from us if it’s a fit.

Tell Omri Amirav-Drory, Ph.D. about your company